Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Project Profile
Share
QR code
Phase II Study of Combination of Hyper-CVAD and Dasatinib with orwithout allogeneic stem cell transplant in Patients with Philadelphia (Ph)Chromosome Positive and/or Bcr-Abl Positive Acute LymphoblasticLeukemia (ALL) (A BMT Study)."
Sponsoring Agencies:
NATL INST OF HLTH NHLB, NATL MARROW DONOR PROGRA
Investigator
John Wingard
Professor Emeritus, Former Deputy Director Of Uf Health Cancer Center, And Former Director Of Bone Marrow Transplant Program
Md-Pediatrics | College-Medicine
3522564033
wingajr@ufl.edu
Funding
Award
$1,099.26
Begin Date
August 1, 2012
End Date
July 1, 2016
Research Terms
Cancer Treatment
Industries
Health Care
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
